Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Aug 4, 2026 8-K
SCHEDULE 13G/A Jul 28, 2026
4 Jul 13, 2026 4
144 Jul 9, 2026
4 Jun 18, 2026 4
144 Jun 17, 2026
8-K Jun 12, 2026 8-K
4 Jun 2, 2026 4
144 Jun 1, 2026
4 May 22, 2026 4
4 May 22, 2026 4
4 May 22, 2026 4
4 May 22, 2026 4
4 May 22, 2026 4
4 May 22, 2026 4
4 May 22, 2026 4
8-K May 22, 2026 8-K
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G May 15, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 14, 2026
4 May 11, 2026 4
10-Q May 5, 2026 10-Q
8-K May 5, 2026 8-K
← Newer Page 2 of 27 · 658 filings Older →